Skip to main content
SpringerLink
Log in

Pulmonary Manifestations of Autoinflammatory Disorders

  • Chapter
  • First Online:
Pulmonary Manifestations of Primary Immunodeficiency Diseases

Abstract

Respiratory complications of autoinflammatory disorders (AID) are known as a significant cause of morbidity and mortality in the world. Rheumatologic complications, particularly, have been seen in patients with interstitial lung disease in remarkable rates. Among the most frequently associated rheumatologic AIDs with pulmonary complications are systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), polymyositis-dermatomyositis (PM-DM), Sjogren’s syndrome (SjS), ankylosing spondylitis (AS), Behçet’s disease (BD), autoimmune pancreatitis, Wegener granulomatosis, Churg-Strauss syndrome, adult-onset Still’s disease (AOSD), familial Mediterranean fever (FMF), inflammatory bowel disease (IBD), Cherubism, and chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. With respect to clinical manifestations, initiation of pulmonary involvement in these disorders is different. In some patients, the pulmonary complications occur before the AID or are a manifestation after disease development. Furthermore, there is a wide range of clinical manifestations in these diseases that can be moderate as subclinical abnormalities to more severe forms like acute respiratory failure. Regarding histopathological complications, the main specification of pulmonary involvement in AID is inflammation in one or both lungs. The inflammatory reactions can be acute to chronic, in which remodeling of the lungs by fibrosis is commonly seen. Most of the times, the inflammatory outcomes are not specific and certain, but a distinctive series of responses or anatomic involvement may be seen in particular AID. Moreover, unique histopathological manifestations such as rheumatoid nodules may be observed. Herein, we determined to have an overview on different aspects of common pulmonary pathologic complications of AID with respect to clinical and radiologic observations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Müller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Rev Rheumatol. 2005;1(2):102.

    Article  CAS  Google Scholar 

  2. McInnes IB, O’dell JR. State-of-the-art: rheumatoid arthritis. Ann Rheum Dis. 2010;69(11):1898–906.

    Article  CAS  PubMed  Google Scholar 

  3. de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, et al. CD4+ CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol. 2004;172(10):6435–43.

    Article  PubMed  Google Scholar 

  4. Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheumatol. 2004;50(5):1400–11.

    Article  CAS  Google Scholar 

  5. Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999;23(6):941–8.

    Article  CAS  PubMed  Google Scholar 

  6. Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid arthritis–related lung diseases: CT findings. Radiology. 2004;232(1):81–91.

    Article  PubMed  Google Scholar 

  7. White ES, Tazelaar HD, Lynch Iii JP, editors. Bronchiolar complications of connective tissue diseases. Semin Respir Crit Care Med; 2003. Copyright© 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.:+ 1 (212) 584-4662.

    Google Scholar 

  8. Lee H-K, Kim DS, Yoo B, Seo JB, Rho J-Y, Colby TV, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest J. 2005;127(6):2019–27.

    Article  Google Scholar 

  9. Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994;193(2):375–82.

    Article  CAS  PubMed  Google Scholar 

  10. Colby TV. Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med. 1998;19(4):587–612.

    Article  CAS  PubMed  Google Scholar 

  11. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis 1, 2. Am Rev Respir Dis. 1985;131(5):770–7.

    CAS  PubMed  Google Scholar 

  12. Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J. 2001;18(32 suppl):69s–80s.

    Google Scholar 

  13. Yoshinouchi T, Ohtsuki Y, Fujita J, Yamadori I, Bandoh S, Ishida T, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int. 2005;26(2):121–5.

    Article  CAS  PubMed  Google Scholar 

  14. Hakala M, Pääkkö P, Huhti E, Tarkka M, Sutinen S. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol. 1990;9(4):452–60.

    Article  CAS  PubMed  Google Scholar 

  15. Tansey D, Wells A, Colby TV, Ip S, Nikolakoupolou A, Du Bois R, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004;44(6):585–96.

    Article  CAS  PubMed  Google Scholar 

  16. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136–47.

    Article  CAS  PubMed  Google Scholar 

  17. Devouassoux G, Cottin V, Lioté H, Marchand E, Frachon I, Schuller A, et al. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J. 2009;33(5):1053–61.

    Article  CAS  PubMed  Google Scholar 

  18. Schwarz MI, Zamora MR, Hodges TN, Chan ED, Bowler RP, Tuder RM. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest. 1998;113(6):1609–15.

    Article  CAS  PubMed  Google Scholar 

  19. Rice AJ, Wells AU, Bouros D, du Bois RM, Hansell DM, Polychronopoulos V, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am J Clin Pathol. 2003;119(5):709–14.

    Article  PubMed  Google Scholar 

  20. Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheumatol. 2013;65(11):2737–47.

    Article  Google Scholar 

  21. Kim EA, Johkoh T, Lee KS, Ichikado K, Koh E-M, Kim TS, et al. Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr. 2001;25(5):757–63.

    Article  CAS  PubMed  Google Scholar 

  22. Cozzi F, Corona MC, Rizzi M, Dus C, Durigon N, Mancin S, et al. Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities. Reumatismo. 2001;53(1):55–62.

    PubMed  Google Scholar 

  23. Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232(2):560–7.

    Article  PubMed  Google Scholar 

  24. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest J. 2007;132(3):773–9.

    Article  Google Scholar 

  25. Pandey AK, Wilcox P, Mayo JR, Sin D, Moss R, Ellis J, et al. Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: a retrospective analysis. Can Assoc Radiol J. 2010;61(5):291–6.

    Article  PubMed  Google Scholar 

  26. Bhalla M, Silver R, Shepard J, McLoud T. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol. 1993;161(2):269–72.

    Article  CAS  PubMed  Google Scholar 

  27. Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):121–7.

    PubMed  Google Scholar 

  28. Fujita J, Tokuda M, Bandoh S, Yang Y, Fukunaga Y, Hojo S, et al. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int. 2001;20(2):81–4.

    Article  CAS  PubMed  Google Scholar 

  29. De Souza RB, Borges CT, Capelozzi VL, Parra ER, Jatene FB, Kavakama J, et al. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis. Respiration. 2009;77(4):389–97.

    Article  PubMed  Google Scholar 

  30. Johnson DA, Drane WE, Curran J, Cattau EL, Ciarleglio C, Khan A, et al. Pulmonary disease in progressive systemic sclerosis: a complication of gastroesophageal reflux and occult aspiration? Arch Intern Med. 1989;149(3):589–93.

    Article  CAS  PubMed  Google Scholar 

  31. Montesi A, Pesaresi A, Cavalli ML, Ripa G, Candela M, Gabrielli A. Oropharyngeal and esophageal function in scleroderma. Dysphagia. 1991;6(4):219–23.

    Article  CAS  PubMed  Google Scholar 

  32. Yousem SA. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol. 1990;21(5):467–74.

    Article  CAS  PubMed  Google Scholar 

  33. Launay D, Mouthon L, Hachulla E, Pagnoux C, de Groote P, Remy-Jardin M, et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol. 2007;34(5):1005–11.

    PubMed  Google Scholar 

  34. Bridges AJ, Hsu K, Dias-Arias AA, Chechani V. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol. 1992;19(7):1136–40.

    CAS  PubMed  Google Scholar 

  35. Muir TE, Tazelaar HD, Colby TV, Myers JL, editors. Organizing diffuse alveolar damage associated with progressive systemic sclerosis. Mayo Clin Proc. 1997;72:639–42. Elsevier.

    Google Scholar 

  36. Griffin M, Robb J, Martin J. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis. Thorax. 1990;45(11):903–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatol. 1982;25(11):1271–7.

    Article  CAS  Google Scholar 

  38. Bankier AA, Kiener HP, Wiesmayr MN, Fleischmann D, Kontrus M, Herold CJ, et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology. 1995;196(3):835–40.

    Article  CAS  PubMed  Google Scholar 

  39. Fenlon H, Doran M, Sant S, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol. 1996;166(2):301–7.

    Article  CAS  PubMed  Google Scholar 

  40. Sant S, Doran M, Fenelon H, Breatnach E. Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol. 1996;15(5):507–13.

    Google Scholar 

  41. Ooi G, Ngan H, Peh W, Mok M, Ip M. Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clin Radiol. 1997;52(10):775–81.

    Article  CAS  PubMed  Google Scholar 

  42. Cheema GS, Quismorio FP Jr. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med. 2000;6(5):424–9.

    Article  CAS  PubMed  Google Scholar 

  43. Matthay RA, Schwarz MI, Petty TL, Stanford RE, Gupta RC, Sahn SA, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine. 1975;54(5):397–410.

    Article  CAS  PubMed  Google Scholar 

  44. Susanto I, Peters JI. Acute lupus pneumonitis with normal chest radiograph. Chest. 1997;111(6):1781–3.

    Article  CAS  PubMed  Google Scholar 

  45. Gruden JF, Webb WR, Warnock M. Centrilobular opacities in the lung on high-resolution CT: diagnostic considerations and pathologic correlation. AJR Am J Roentgenol. 1994;162(3):569–74.

    Article  CAS  PubMed  Google Scholar 

  46. Oki H, Aoki T, Saito K, Yamashita Y, Hanamiya M, Hayashida Y, et al. Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome. Eur J Radiol. 2012;81(6):1335–9.

    Article  PubMed  Google Scholar 

  47. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med. 1981;71(5):791–8.

    Article  CAS  PubMed  Google Scholar 

  48. Myers JL, Katzenstein A-LA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol. 1986;85(5):552–6.

    Article  CAS  PubMed  Google Scholar 

  49. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus–do we need to know about it? Lupus. 2008;17(4):274–7.

    Article  CAS  PubMed  Google Scholar 

  50. Johnson S, Granton J. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev. 2011;20(122):277–86.

    Article  CAS  PubMed  Google Scholar 

  51. Wakaki K, Koizumi F, Fukase M. Vascular lesions in systemic lupus erythematosus (SLE) with pulmonary hypertension. Pathol Int. 1984;34(3):593–604.

    Article  CAS  Google Scholar 

  52. Asherson R, Hackett D, Gharavi A, Harris E, Kennedy H, Hughes G. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases. J Rheumatol. 1986;13(2):416–20.

    CAS  PubMed  Google Scholar 

  53. Yokoi T, Tomita Y, Fukaya M, Ichihara S. Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions. Arch Pathol Lab Med. 1998;122(5):467.

    CAS  PubMed  Google Scholar 

  54. Roncoroni AJ, Alvarez C, Molinas F. Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration. 1992;59(1):52–6.

    Article  CAS  PubMed  Google Scholar 

  55. Simonson J, Schiller N, Petri M, Hellmann D. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol. 1989;16(7):918–25.

    CAS  PubMed  Google Scholar 

  56. Fayemi A. The lung in systemic lupus erythematosus: a clinico-pathologic study of 20 cases. Mt Sinai J Med New York. 1974;42(2):110–8.

    Google Scholar 

  57. Yood R, Steigman D, Gill L. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus. 1995;4(2):161–3.

    Article  CAS  PubMed  Google Scholar 

  58. Marenco J, Sanchez-Burson J, Campos JR, Jimenez M, Garcia-Bragado F. Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol. 1994;13(3):525–7.

    Article  CAS  PubMed  Google Scholar 

  59. Min J, Hong Y, Park S, Park J, Lee S, Lee Y, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol. 1997;24(11):2254–7.

    CAS  PubMed  Google Scholar 

  60. Gammon RB, Bridges TA, Al-Nezir H, Alexander CB, Kennedy JI. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest. 1992;102(4):1171–4.

    Article  CAS  PubMed  Google Scholar 

  61. Filipek MS, Thompson ME, Wang P-L, Gosselin MV, Primack SL. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: radiographic and high-resolution CT findings. J Thorac Imaging. 2004;19(3):200–3.

    Article  PubMed  Google Scholar 

  62. Harvey Eisenberg M, Sherwin RP. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med. 1973;79:37–45.

    Article  Google Scholar 

  63. Koh W, Boey M. Open lung biopsy in systemic lupus erythematosus patients with pulmonary disease. Ann Acad Med Singap. 1993;22(3):323–5.

    CAS  PubMed  Google Scholar 

  64. Benisch B, Peison B. The association of lymphocytic interstitial pneumonia and systemic lupus erythematosus. Mt Sinai J Med New York. 1978;46(4):398–41.

    Google Scholar 

  65. Hariri LP, Unizony S, Stone J, Mino-Kenudson M, Sharma A, Matsubara O, et al. Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: a case report and review of the literature. Pathol Int. 2010;60(11):755–9.

    Article  PubMed  Google Scholar 

  66. Schwarz MI. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging. 1992;7(2):46–54.

    Article  CAS  PubMed  Google Scholar 

  67. Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Ichikado K, Nakamura H. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging. 1996;11(4):250–9.

    Article  CAS  PubMed  Google Scholar 

  68. Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest J. 2003;123(4):1096–103.

    Article  Google Scholar 

  69. Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol. 1997;169(1):83–7.

    Article  CAS  PubMed  Google Scholar 

  70. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Am Rev Respir Dis. 1990;141(3):727–31.

    Article  CAS  PubMed  Google Scholar 

  71. Selva-O’Callaghan A, Labrador-Horrillo M, Munoz-Gall X, Martinez-Gomez X, Majo-Masferrer J, Solans-Laque R, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus. 2005;14(7):534–42.

    Article  PubMed  Google Scholar 

  72. Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol. 2005;32(1):58–64.

    PubMed  Google Scholar 

  73. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian P, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003;22(2):245–50.

    Article  CAS  PubMed  Google Scholar 

  74. Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Care Res. 2002;47(6):614–22.

    Article  CAS  Google Scholar 

  75. Ito M, Kaise S, Suzuki S, Kazuta Y, Sato Y, Miyata M, et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol. 1999;18(6):462–7.

    Article  CAS  PubMed  Google Scholar 

  76. Fata F, Rathore R, Schiff C, Herzlich BC. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J. 1997;90(2):227–30.

    Article  CAS  PubMed  Google Scholar 

  77. Hsue Y, Paulus H, Coulson W. Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with longterm survival. J Rheumatol. 1993;20(5):877–9.

    CAS  PubMed  Google Scholar 

  78. Labirua A, Lundberg IE. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol. 2010;22(6):633–8.

    Article  PubMed  Google Scholar 

  79. Yousem SA, Gibson K, Kaminski N, Oddis CV, Ascherman DP. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Modern Pathol. 2010;23(6):874.

    Article  CAS  Google Scholar 

  80. Lee C-S, Chen T-L, Tzen C-Y, Lin F-J, Peng M-J, Wu C-L, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002;21(5):391–6.

    Article  PubMed  Google Scholar 

  81. Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest J. 2009;136(5):1341–7.

    Article  Google Scholar 

  82. Bonnefoy O, Ferretti G, Calaque O, Coulomb M, Begueret H, Beylot-Barry M, et al. Serial chest CT findings in interstitial lung disease associated with polymyositis–dermatomyositis. Eur J Radiol. 2004;49(3):235–44.

    Article  PubMed  Google Scholar 

  83. Schwarz MI, Sutarik JM, Nick JA, Leff JA, Emlen JW, Tuder RM. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med. 1995;151(6):2037–40.

    Article  CAS  PubMed  Google Scholar 

  84. Bunch TW, Tancredi RG, Lie J. Pulmonary hypertension in polymyositis. Chest. 1981;79(1):105–7.

    Article  CAS  PubMed  Google Scholar 

  85. Aisa Y, Yokomori H, Kashiwagi K, Nagata S, Yanagisawa R, Takahashi M, et al. Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection. Intern Med. 2001;40(11):1109–12.

    Article  CAS  PubMed  Google Scholar 

  86. Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, et al. Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol. 2010;162(2):337–44.

    Article  CAS  PubMed  Google Scholar 

  87. Castañeda-Pomeda M, Prieto-González S, Grau JM. Antisynthetase syndrome and malignancy: our experience. JCR J Clin Rheumatol. 2011;17(8):458.

    Article  PubMed  Google Scholar 

  88. Shiboski S, Shiboski C, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res. 2012;64(4):475–87.

    Article  CAS  Google Scholar 

  89. Meyer CA, Pina JS, Taillon D, Godwin JD. Inspiratory and expiratory high-resolution CT findings in a patient with Sjögren’s syndrome and cystic lung disease. AJR Am J Roentgenol. 1997;168(1):101–3.

    Article  CAS  PubMed  Google Scholar 

  90. Franquet T, Gimenez A, Monill JM, Diaz C, Geli C. Primary Sjögren’s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol. 1997;169(3):655–8.

    Article  CAS  PubMed  Google Scholar 

  91. Koyama M, Johkoh T, Honda O, Mihara N, Kozuka T, Tomiyama N, et al. Pulmonary involvement in primary Sjögren’s syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging. 2001;16(4):290–6.

    Article  CAS  PubMed  Google Scholar 

  92. Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282–9.

    Article  CAS  PubMed  Google Scholar 

  93. Watanabe M, Naniwa T, Hara M, Arakawa T, Maeda T. Pulmonary manifestations in Sjögren’s syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol. 2010;37(2):365–73.

    Article  PubMed  Google Scholar 

  94. Lohrmann C, Uhl M, Warnatz K, Ghanem N, Kotter E, Schaefer O, et al. High-resolution CT imaging of the lung for patients with primary Sjögren’s syndrome. Eur J Radiol. 2004;52(2):137–43.

    Article  PubMed  Google Scholar 

  95. Hansen LA, Prakash UB, Colby TV, editors. Pulmonary lymphoma in Sjögren’s syndrome. Mayo Clin Proc. 1989;64:920–31. Elsevier.

    Google Scholar 

  96. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632–8.

    Article  PubMed  Google Scholar 

  97. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjogren syndrome. Chest J. 2006;130(5):1489–95.

    Article  Google Scholar 

  98. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89(6):888–92.

    Article  CAS  PubMed  Google Scholar 

  99. Jeong YJ, Lee KS, Chung MP, Han J, Chung MJ, Kim K-I, et al. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr. 2004;28(6):776–81.

    Article  PubMed  Google Scholar 

  100. Lee I-J, Kim SH, Koo SH, Kim HB, Hwang DH, Lee KS, et al. Bronchus-associated lymphoid tissue (BALT) lymphoma of the lung showing mosaic pattern of inhomogeneous attenuation on thin-section CT: a case report. Korean J Radiol. 2000;1(3):159–61.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Nakamura N, Yamada G, Itoh T, Suzuki A, Morita-Ichimura S, Teramoto S, et al. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjögren’s syndrome. Intern Med. 2002;41(4):309–11.

    Article  PubMed  Google Scholar 

  102. Byrd SL, Case BA, Boulware DW. Pulmonary manifestations of rheumatic disease. Postgrad Med. 1993;93(1):149–66.

    Article  CAS  PubMed  Google Scholar 

  103. Rumancik WM, Firooznia H, Davis MS, Leitman BS, Golimbu C, Rafii M, et al. Fibrobullous disease of the upper lobes: an extraskeletal manifestation of ankylosing spondylitis. J Comput Tomogr. 1984;8(3):225–9.

    Article  CAS  PubMed  Google Scholar 

  104. Gupta S, Johnston W. Apical pulmonary disease in ankylosing spondylitis. N Z Med J. 1978;88(619):186–8.

    CAS  PubMed  Google Scholar 

  105. Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases 1, 2. Am Rev Respir Dis. 1979;119(3):471–503.

    CAS  PubMed  Google Scholar 

  106. Wolson AH, Rohwedder JJ. Upper lobe fibrosis in ankylosing spondylitis. Am J Roentgenol. 1975;124(3):466–71.

    Article  CAS  Google Scholar 

  107. Tanoue LT. Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjogren’s syndrome, and relapsing polychondritis. J Thorac Imaging. 1992;7(2):62.

    Article  CAS  PubMed  Google Scholar 

  108. Chakera T, Howarth F, Kendall M, Lawrence D, Whitfield A. The chest radiograph in ankylosing spondylitis. Clin Radiol. 1975;26:455–9.

    Article  CAS  PubMed  Google Scholar 

  109. Appelrouth D, Gottlieb N. Pulmonary manifestations of ankylosing spondylitis. J Rheumatol. 1975;2(4):446–53.

    CAS  PubMed  Google Scholar 

  110. Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in behcet disease: a cumulative analysis. Chest J. 2005;127(6):2243–53.

    Article  Google Scholar 

  111. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002;51(1):1–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003;98(12):2811.

    Article  PubMed  Google Scholar 

  113. Hirano K, Kawabe T, Komatsu Y, Matsubara S, Togawa O, Arizumi T, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J. 2006;36(1):58–61.

    Article  CAS  PubMed  Google Scholar 

  114. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488–98.

    Article  CAS  PubMed  Google Scholar 

  115. Aberle D, Gamsu G, Lynch D. Thoracic manifestations of Wegener granulomatosis: diagnosis and course. Radiology. 1990;174(3):703–9.

    Article  CAS  PubMed  Google Scholar 

  116. Cordier J-F, Valeyre D, Guillevin L, Loire R, Brechot J-M. Pulmonary Wegener's granulomatosis: a clinical and imaging study of 77 cases. Chest. 1990;97(4):906–12.

    Article  CAS  PubMed  Google Scholar 

  117. Kuhlman JE, Hruban RH, Fishman EK. Wegener granulomatosis: CT features of parenchymal lung disease. J Comput Assist Tomogr. 1991;15(6):948–52.

    Article  CAS  PubMed  Google Scholar 

  118. Maskell G, Lockwood C, Flower C. Computed tomography of the lung in Wegener’s granulomatosis. Clin Radiol. 1993;48(6):377–80.

    Article  CAS  PubMed  Google Scholar 

  119. Stübiger N, Zierhut M. Churg-Strauss syndrome. In: Intraocular inflammation. Berlin: Springer; 2016. p. 761–5.

    Chapter  Google Scholar 

  120. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine. 1984;63(2):65–81.

    Article  CAS  PubMed  Google Scholar 

  121. Worthy SA, Müller N, Hansell DM, Flower C. Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. AJR Am J Roentgenol. 1998;170(2):297–300.

    Article  CAS  PubMed  Google Scholar 

  122. Jaqua NT, Finger D, Hawley JS. Adult-onset Still’s disease masquerading as sepsis in an asplenic active duty soldier. Case Rep Med. 2012;2012:349521.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Duburcq T, Delannoy P, Sivova N, Leroy O, editors. Adult onset Still’s disease revealed by a myocarditis. Ann Fr Anesth Reanim. 2013;32:50–2.

    Google Scholar 

  124. Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008;22(5):773–92.

    Article  PubMed  Google Scholar 

  125. Sirnes PA, Tendera M, Vardas P, Widimsky P. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30:2493–537.

    Article  Google Scholar 

  126. Efthimiou P, Kadavath S, Mehta B. Life-threatening complications of adult-onset Still’s disease. Clin Rheumatol. 2014;33(3):305–14.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19(3):424–30.

    CAS  PubMed  Google Scholar 

  128. Zen A, Yamashita N, Ueda M, Asakawa Y, Yoshikawa Y, Funai T, et al. A case of adult Still’s disease with pulmonary hypertension. Ryumachi[Rheumatism]. 1990;30(1):45–52.

    CAS  Google Scholar 

  129. Chen C, Chen H, Wang H, Liao H, Chou C, Huang D. Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. J Microbiol Immunol Infect. 2006;39(2):162.

    PubMed  Google Scholar 

  130. Campos M, Schiopu E. Pulmonary arterial hypertension in adult-onset Still’s disease: rapid response to anakinra. Case Rep Rheumatol. 2012;2012:537613.

    PubMed  PubMed Central  Google Scholar 

  131. Şahan C, Cengiz K. Pulmonary amyloidosis in familial Mediterranean fever. Acta Clin Belg. 2006;61(3):147–51.

    Article  PubMed  Google Scholar 

  132. Ozen S. Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol. 2009;27(2 Suppl 53):S29–31.

    CAS  PubMed  Google Scholar 

  133. Lidar M, Pras M, Langevitz P, Livneh A. Thoracic and lung involvement in familial Mediterranean fever (FMF). Clin Chest Med. 2002;23(2):505–11.

    Article  PubMed  Google Scholar 

  134. Kushima H, Ishii H, Ishii K, Kadota J-i. Pulmonary necrotizing granulomas in a patient with familial Mediterranean fever. Mod Rheumatol. 2015;25(5):806–9.

    Article  PubMed  Google Scholar 

  135. Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237.

    PubMed  PubMed Central  Google Scholar 

  136. Rodriguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK. Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol WJG. 2007;13(46):6156.

    Article  CAS  PubMed  Google Scholar 

  137. Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med. 1976;136(4):454–9.

    Article  CAS  PubMed  Google Scholar 

  138. Spira A, Grossman R, Balter M. Large airway disease associated with inflammatory bowel disease. Chest. 1998;113(6):1723–6.

    Article  CAS  PubMed  Google Scholar 

  139. Valletta E, Bertini M, Sette L, Braggion C, Pradal U, Zannoni M. Early bronchopulmonary involvement in Crohn disease: a case report. BMC Gastroenterol. 2001;1(1):13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Iwama T, Higuchi T, Imajo M, Akagawa S, Matsubara O, Mishima Y. Tracheo-bronchitis as a complication of Crohn’s disease—a case report—. Surg Today. 1991;21(4):454–7.

    CAS  Google Scholar 

  141. Kuzniar T, Sleiman C, Brugiere O, Groussard O, Mal H, Mellot F, et al. Severe tracheobronchial stenosis in a patient with Crohn’ disease. Eur Respir J. 2000;15(1):209–12.

    CAS  PubMed  Google Scholar 

  142. Hamada S, Ito Y, Imai S, Oguma T, Niimi A, Mishima M. Effect of inhaled corticosteroid therapy on CT scan-estimated airway dimensions in a patient with chronic bronchitis related to ulcerative colitis. Chest J. 2011;139(4):930–2.

    Article  Google Scholar 

  143. Peradzyńska J, Krenke K, Lange J, Banaszkiewicz A, Łazowska-Przeorek I, Radzikowski A, et al. Low prevalence of pulmonary involvement in children with inflammatory bowel disease. Respir Med. 2012;106(7):1048–54.

    Article  PubMed  Google Scholar 

  144. Desai D, Patil S, Udwadia Z, Maheshwari S, Abraham P, Joshi A. Pulmonary manifestations in inflammatory bowel disease: a prospective study. Indian J Gastroenterol. 2011;30(5):225.

    Article  PubMed  Google Scholar 

  145. Desai SJ, Gephardt GN, Stoller JK. Diffuse panbronchiolitis preceding ulcerative colitis. Chest. 1989;95(6):1342–4.

    Article  CAS  PubMed  Google Scholar 

  146. Vandenplas O, Casel S, Delos M, Trigaux J-P, Melange M, Marchand E. Granulomatous bronchiolitis associated with Crohn’s disease. Am J Respir Crit Care Med. 1998;158(5):1676–9.

    Article  CAS  PubMed  Google Scholar 

  147. Butland R, Cole P, Citron K, Turner-Warwick M. Chronic bronchial suppuration and inflammatory bowel disease. QJM An Int J Med. 1981;50(1):63–75.

    CAS  Google Scholar 

  148. Wilcox P, Miller R, Miller G, Heath J, Nelems B, Muller N, et al. Airway involvement in ulcerative colitis. Chest. 1987;92(1):18–22.

    Article  CAS  PubMed  Google Scholar 

  149. Nakamura M, Inoue T, Ishida A, Miyazu YM, Kurimoto N, Miyazawa T. Endobronchial ultrasonography and magnetic resonance imaging in tracheobronchial stenosis from ulcerative colitis. J Bronchol Intervent Pulmonol. 2011;18(1):84–7.

    Article  Google Scholar 

  150. Shulimzon T, Rozenman J, Perelman M, Bardan E, Ben-Dov I. Necrotizing granulomata in the lung preceding colonic involvement in 2 patients with Crohn’s disease. Respiration. 2007;74(6):698–702.

    Article  PubMed  Google Scholar 

  151. Piotrowski WJ, Zieliñski KW, Kozłowska A, Górski P. Atypical lung changes in a 19-year-old woman with Crohn’s disease. Lung. 2007;185(3):189–90.

    Article  PubMed  Google Scholar 

  152. Golpe R, Mateos A, Pérez-Valcárcel J, Lapeña JA, García-Figueiras R, Blanco J. Multiple pulmonary nodules in a patient with Crohn’s disease. Respiration. 2003;70(3):306–9.

    Article  PubMed  Google Scholar 

  153. Lucero PF, Frey WC, Shaffer RT, Morris MJ. Granulomatous lung masses in an elderly patient with inactive Crohn’s disease. Inflamm Bowel Dis. 2001;7(3):256–9.

    Article  CAS  PubMed  Google Scholar 

  154. Jang EC, Choi SJ, Cho JH, Ryu J-S, Kwak SM, Lee HL, et al. Organizing pneumonia presenting after ulcerative colitis remission. J Thorac Dis. 2013;5(2):E71.

    PubMed  PubMed Central  Google Scholar 

  155. Carratù P, Dragonieri S, Nocerino MC, Trabucco SMR, Lacedonia D, Parisi G, et al. A case of cryptogenic organizing pneumonia occurring in Crohn’s disease. Can Respir J. 2005;12(8):437–9.

    Article  PubMed  Google Scholar 

  156. Adachi Y, Hinoda Y, Takahashi H, Nakagawa N, Sakamoto H, Itoh F, et al. Rheumatoid arthritis associated with ulcerative colitis. J Gastroenterol. 1996;31(4):590–5.

    Article  CAS  PubMed  Google Scholar 

  157. Lu D-G, Ji X-Q, Zhao Q, Zhang C-Q, Li Z-F. Tracheobronchial nodules and pulmonary infiltrates in a patient with Crohn’s disease. World J Gastroenterol WJG. 2012;18(39):5653.

    Article  PubMed  Google Scholar 

  158. Calder C, Lacy D, Raafat F, Weller P, Booth I. Crohn9s disease with pulmonary involvement in a 3 year old boy. Gut. 1993;34(11):1636–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Krishnan S, Banquet A, Newman L, Katta U, Patil A, Dozor AJ. Lung lesions in children with Crohn’s disease presenting as nonresolving pneumonias and response to infliximab therapy. Pediatrics. 2006;117(4):1440–3.

    Article  PubMed  Google Scholar 

  160. Freeman HJ, Davis JE, Prest ME, Lawson EJ. Granulomatous ‘bronchiolitis with necrobiotic pulmonary nodules in Chrohn’s disease. Can J Gastroenterol Hepatol. 2004;18(11):687–90.

    Google Scholar 

  161. Kedziora JA, Wolff M, Chang J. Limited form of Wegener’s granulomatosis in ulcerative colitis. Am J Roentgenol. 1975;125(1):127–33.

    Article  CAS  Google Scholar 

  162. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86(2):202–10.

    Article  CAS  PubMed  Google Scholar 

  163. Kasuga A, Mandai Y, Katsuno T, Sato T, Yamaguchi T, Yokosuka O. Pulmonary complications resembling Wegener’s granulomatosis in ulcerative colitis with elevated proteinase-3 anti-neutrophil cytoplasmic antibody. Intern Med. 2008;47(13):1211–4.

    Article  PubMed  Google Scholar 

  164. Elzouki AN, Eriksson S, Löfberg R, Nässberger L, Wieslander J, Lindgren S. The prevalence and clinical significance of α1-antitrypsin deficiency (PiZ) and anca specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflamm Bowel Dis. 1999;5(4):246–52.

    Article  CAS  PubMed  Google Scholar 

  165. Majewski S, Piotrowski W. Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci AMS. 2015;11(6):1179.

    Article  CAS  PubMed  Google Scholar 

  166. Talwar A, Kunst H, Ngatchu T, Trotter S. A case presentation of a pulmonary complication of ulcerative colitis. BMJ Case Rep. 2013;2013:bcr0220125806.

    Article  PubMed  PubMed Central  Google Scholar 

  167. Mahadeva R, Walsh G, Flower C, Shneerson J. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J. 2000;15(1):41–8.

    Article  CAS  PubMed  Google Scholar 

  168. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest J. 2007;131(2):524–32.

    Article  Google Scholar 

  169. Chikano S, Sawada K, Ohnishi K, Fukunaga K, Tanaka J, Shimoyama T. Interstitial pneumonia accompanying ulcerative colitis. Intern Med. 2001;40(9):883–6.

    Article  CAS  PubMed  Google Scholar 

  170. Ikehara N, Fujimoto K, Sadohara J, Iwamoto R, Tajiri M, Okamoto M, et al. Interstitial pneumonia associated with ulcerative colitis: high-resolution computed tomography and pathologic findings. J Thorac Imaging. 2013;28(1):W21–W3.

    Article  PubMed  Google Scholar 

  171. Faller M, Gasser B, Massard G, Pauli G, Quoix E. Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn’s disease. Respiration. 2000;67(4):459–63.

    Article  CAS  PubMed  Google Scholar 

  172. Songür N, Songür Y, Tüzün M, Dogan I, Tüzün D, Ensari A, et al. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol. 2003;37(4):292–8.

    Article  PubMed  Google Scholar 

  173. Roginsky V, Ivanov A, Ovtchinnikov I, Khonsari R. Familial cherubism: the experience of the Moscow Central Institute for Stomatology and Maxillo-Facial Surgery. Int J Oral Maxillofac Surg. 2009;38(3):218–23.

    Article  CAS  PubMed  Google Scholar 

  174. Battaglia A, Merati A, Magit A. Cherubism and upper airway obstruction. Otolaryngol Head Neck Surg. 2000;122(4):573–4.

    CAS  PubMed  Google Scholar 

  175. Al-Mayouf SM, AlSaleem A, AlMutairi N, AlSonbul A, Alzaid T, Alazami AM, et al. Monogenic interferonopathies: Phenotypic and genotypic findings of CANDLE syndrome and its overlap with C1q deficient SLE. Int J Rheum Dis. 2018;21:208–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Ahmadreza Jamshidi, Saeed Aslani & Mahdi Mahmoudi

Authors
  1. Ahmadreza Jamshidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saeed Aslani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahdi Mahmoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahdi Mahmoudi .

Editor information

Editors and Affiliations

  1. Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Seyed Alireza Mahdaviani

  2. Research Center for Immunodeficiencies Children’s Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jamshidi, A., Aslani, S., Mahmoudi, M. (2019). Pulmonary Manifestations of Autoinflammatory Disorders. In: Mahdaviani, S., Rezaei, N. (eds) Pulmonary Manifestations of Primary Immunodeficiency Diseases . Springer, Cham. https://doi.org/10.1007/978-3-030-00880-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-00880-2_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-00879-6

  • Online ISBN: 978-3-030-00880-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation